Matthias Fischer Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Identification of somatic mutations determining the neuroblastoma phenotype — Parallel 7 Basic Awards Session
• Molecular risk stratification of neuroblastoma patients - using RNA, DNA, or both? — Workshop 4 - Next generation risk stratification: new approaches to identify highest risk patients (or ultra high risk patients)